Amplification of recombinant adenoviral transgene products occurs by inhibition of histone deacetylase

Virology

Volumn 231, Issue 2, 1997, Pages 201-209

  Dion, L David ^a   Goldsmith, Kelly T ^a   Tang, De Chu ^a   Engler, Jeffrey A ^a   Yoshida, Minoru ^b   Garver Jr , Robert I ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; DNA BINDING PROTEIN; HISTONE DEACETYLASE; TRICHOSTATIN A; VIRUS PROTEIN;

ARTICLE; GENE AMPLIFICATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; TRANSCRIPTION REGULATION; TRANSGENE; VIRUS GENE; VIRUS REPLICATION;

EID: 0030984807     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8538     Document Type: Article

References (53)

1. Anisimova E., Prachova K., Roubal J., Vonka V. Effects ofn. Arch. Virol. 81:1984;223-237.
2. Anisimova E., Saemundsen A. K., Roubal J., Vonka V., Klein G. Effects ofn. J. Gen. Virol. 58:1982;163-171.
3. Boffa L. C., Vidali G., Mann R. S., Allfrey V. G. Suppression of histone deacetylationin vivoin vitro. J. Biol. Chem. 253:1978;3364-3366.
4. Bohan C. A., Robinson R. A., Luciw P. A., Srinivasan A. Mutational analysis of sodium butyrate-inducible elements in the human immunodeficiency virus type 1 long terminal repeat. Virology. 172:1989;573-583.
5. Candido E. P. M., Reeves R., Davie J. R. Sodium butyrate inhibits histone deacetylation in cultured cells. Cell. 14:1978;105-113.
6. Charollais R. H., Buquet C., Mester J. Butyrate blocks the accumulation of CDC2 and mRNA in late G1 phase but inhibits both the early and late G1 progression in chemically transformed mouse fibroblasts BP-A31. J. Cell. Physiol. 145:1990;46-52.
7. Chatellard C., Chroboczek J. Synthesis of human adenovirus type 2 fiber protein inEscherichia coli. Gene. 81:1989;267-274.
8. Cleghon V., Piderit A., Brough D. E., Klessig D. F. Phosphorylation of the adenovirus DNA-binding protein and epitope mapping of monoclonal antibodies against it. Virology. 197:1993;564-575.
9. Collins S. J., Ruscetti F. W., Gallagher R. E., Gallo R. C. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc. Natl. Acad. Sci. USA. 1978:1978;2458-2462.
10. Cousens L. S., Gallwitz D., Alberts B. M. Different accessibilities in chromatin to histone acetylase. J. Biol. Chem. 254:1979;1716-1723.
11. Daniell E. Cells inhibited byn. Virology. 107:1980;514-519.
12. D'Anna J. A., Tobey R. A., Gurley L. R. Concentration-dependent effects of sodium butyrate in Chinese hamster cells: Cell-cycle progression, inner-histone acetylation, histone H1 dephosphorylation, and induction of an H1-like protein. Biochemistry. 19:1980;2656-2671.
13. Dion L. D., Goldsmith K. T., Garver R. I. Jr. Quantitative andin vivo. Can. Gene Ther. 3:1996a;230-237.
14. Dion L. D., Goldsmith K. T., Strong T. V., Bilbao G., Curiel D. T., Garver R. I. Jr. E1A transcripts amplify adenovirus-mediated tumor reduction. Gene Ther. 3:1996b;1021-1025.
15. +. J. Virol. 70:1996;6314-6322.
16. Freeman H. J. Effects of differing concentrations of sodium butyrate on rat intestinal neoplasia. Gastroenterology. 91:1986;596-602.
17. Gamet L., Daviaud D., Denis-Pouxviel C., Remesy C., Murat J.-C. Effects of short-chain fatty acids on growth and differentiation of the human colon-cancer cell line HT29. Int. J. Can. 52:1992;286-289.
18. Goldberg Y. P., Leaner V. D., Parker M. I. Elevation of large-T antigen production by sodium butyrate treatment of SV40-transformed WI-38 fibroblasts. J. Cell. Biochem. 49:1992;74-81.
19. Goldsmith K. T., Curiel D. T., Engler J. A., Garver R. I. Jr. Trans. Hum. Gene Ther. 5:1994;1341-1348.
20. Goldsmith K. T., Gammon R. B., Garver R. I. Jr. Modulation of bFGF in lung fibroblasts by TGF-β and PDGF. Am. J. Physiol. (Lung Cell. Mol. Physiol.). 261:1991;L378-L385.
21. Herz J., Gerard R. D. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc. Natl. Acad. Sci. USA. 90:1993;2812-2816.
22. Hong J. S., Engler J. A. The amino terminus of the adenovirus fiber protein encodes the nuclear localization signal. Virology. 185:1991;758-767.
23. Howard M. A., Wardwell S., Albert D. M. Effect of butyrate and corticosteroids on retinoblastoma in vitro and in vivo. Invest. Ophthalmol. Visual Sci. 32:1991;1711-1713.
24. Ito Y., Kawanishi M., Harayama T., Takabayashi. Combined effect of the extracts from Croton tiglium, Euphorbia lathyris or Euphorbia tirucalli andn. Cancer Lett. 12:1981;175-180.
25. Januszewicz E., Rabizadeh E., Novogradsky A., Shaklai M. Butyric acid: Inhibition of non-leukemic and chronic myeloid leukemia granulocyte macrophage clonal growth. Med. Oncol. Tumor Pharmacother. 5:1988;259-263.
26. Jass J. R. Diet, butyric acid and differentiation of gastrointestinal tract tumors. Med. Hypotheses. 18:1985;113-118.
27. Kijima M., Yoshida M., Sugita K., Horinouchi S., Beppu T. Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase. J. Biol. Chem. 268:1993;22429-22435.
28. Klessig D. F. Two adenovirus mRNAs have a common 5′ terminal leader sequence encoded at least 10 kb upstream from their main coding regions. Cell. 12:1977;9-21.
29. Kruijer W., van Schaik F. M. A., Sussenbach J. S. Structure and organization of the gene coding for the DNA binding protein of adenovirus type 5. Nucleic Acids Res. 9:1981;4439-4457.
30. Leder A., Leder P. Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemia cells. Cell. 5:1975;319-322.
31. Miller A. A., Kurschel E., Osieka R., Schmidt C. G. Clinical pharmacology of sodium butyrate in patients with acute leukemia. Eur. J. Can. Clin. Oncol. 23:1987;1283-1287.
32. Nudelman A., Ruse M., Aviram A., Rabizadeh E., Shaklai M., Zimrah Y., Rephaeli A. Novel anticancer prodrugs of butyric acid. J. Med. Chem. 35:1992;687-694.
33. Otaka M., Singhal A., Hakomori S. Antibody-mediated targeting of differentiation inducers to tumor cells: Inhibition of colonic cancer cell growthin vitroin vivo. Biochem. Biophys. Res. Commun. 158:1989;202-208.
34. Pilder S., Logan J., Shenk T. Deletion of the gene encoding the adenovirus 5 early region 1B 21,000-molecular-weight polypeptide leads to degradation of viral and host cell DNA. J. Virol. 52:1984;664-671.
35. Planchon P., Raux H., Magnien V., Ronco G., Villa P., Crepin M., Brouty-Boye D. New stable butyrate derivatives alter proliferation and differentiation in human mammary cells. Int. J. Can. 48:1991;443-449.
36. Pouillart P., Ronco G., Cerutti I., Trouvin J. H., Pieri F., Villa P. Pharmacokinetic studies ofn. J. Pharm. Sci. 81:1992;241-244.
37. Remesy C., Demigne C. Partition and absorption of volatile fatty acids in the alimentary canal of the rat. Ann. Rech. Vet. 7:1976;39-55.
38. Saemundsen A. K., Kallin B., Klein G. Effect ofn. Virology. 107:1980;557-561.
39. Sealy L., Chalkley R. The effect of sodium butyrate on histone modification. Cell. 14:1978;115-121.
40. Shadan F. F., Cowsert L. M., Villarreal F. P. n. J. Virol. 68:1994;4785-4796.
41. Sundquist B., Pettersson U., Thelander L., Philipson L. Structural proteins of adenoviruses. Virology. 51:1973;252-256.
42. Tanaka J., Sadanari H., Sato H., Fukuda S. Sodium butyrate-inducible replication of human cytomegalovirus. Virology. 185:1991;271-280.
43. Tang D. C., Johnston S. A., Carbone D. P. Butyrate-inducible and tumor-restricted gene expression by adenovirus vectors. Can. Gene Ther. 1:1994;15-20.
44. Tang D. C., Taylor M. W. Transcriptional activation of the adenine phosphoribosyltransferase promoter by an upstream butyrate-induced Moloney murine sarcoma virus enhancer-promoter element. J. Virol. 64:1990;2907-2911.
45. Taunton J., Hassig C. A., Schreiber S. L. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science. 272:1996;408-411.
46. Vidali G., Boffa L. C., Mann R. S., Allfrey V. G. Reversible effects of Na-butyrate on histone acetylation. Biochem. Biophys. Res. Commun. 82:1978;223-227.
47. Wawra E., Pockl E., Mullner E., Wintersberger E. Effect of sodium butyrate on induction of cellular and viral DNA syntheses in polyoma virus-infected mouse kidney cells. J. Virol. 38:1981;973-981.
48. Wintersberger E., Mudrak I., Wintersberger U. Butyrate inhibits fibroblasts at a control point in the GI phase. J. Cell. Biochem. 21:1983;239-247.
49. Yamamoto I., Matsunaga T., Sakata K., Nakamura Y., Doi S., Hanmyou F. Histone hyperacetylation plays a role in augmentation of IL-4-induced IgE production in LPS-stimulated murine B-lymphocytes by sodium butyrate. J. Biochem. 119:1996;1056-1061.
50. Yang Y., Li Q., Ertl H. C. J., Wilson J. M. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:1995;2004-2015.
51. Yoshida M., Kijima M., Akita M., Beppu T. Potent and specific inhibition of mammalian histone deacetylase bothin vivoin vitro. J. Biol. Chem. 265:1990;17174-17179.
52. Zain S., Sambrook J., Roberts R. J., Keller W., Fried M., Dunn A. R. Nucleotide sequence analysis of the leader segments in a cloned copy of adenovirus 2 fiber mRNA. Cell. 16:1979;851-861.
53. Zhai Y., Yang J. C., Kawakami Y., Spiess P., Wadsworth S. C., Cardoza L. M., Couture L. A., Smith A. E., Rosenberg S. A. Antigen-specific tumor vaccines. J. Immunol. 156:1996;700-710.